Huang H, Li L, Zhu J, Xu D, Wan P, Qiu B
Front Pediatr. 2025; 13:1502761.
PMID: 40061426
PMC: 11885259.
DOI: 10.3389/fped.2025.1502761.
Almeida-Nunes D, Silva J, Nunes M, Silva P, Silvestre R, Dinis-Oliveira R
Int J Mol Sci. 2024; 25(22).
PMID: 39596005
PMC: 11594113.
DOI: 10.3390/ijms252211935.
Marzeta-Assas P, Jacenik D, Zaslona Z
Int J Mol Sci. 2024; 25(18).
PMID: 39337272
PMC: 11431790.
DOI: 10.3390/ijms25189782.
Wang T, Cui S, Lyu C, Wang Z, Li Z, Han C
Heliyon. 2024; 10(17):e36155.
PMID: 39263156
PMC: 11388765.
DOI: 10.1016/j.heliyon.2024.e36155.
Gao J, You T, Liu J, Yang L, Liu Y, Wang Y
Cell Biochem Biophys. 2024; 82(3):1681-1691.
PMID: 38888871
DOI: 10.1007/s12013-024-01334-5.
Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma.
Yang S, Yang X, Hou Z, Zhu L, Yao Z, Zhang Y
Heliyon. 2024; 10(7):e29215.
PMID: 38623200
PMC: 11016731.
DOI: 10.1016/j.heliyon.2024.e29215.
Clinical research progress of ridaforolimus (AP23573, MK8668) over the past decade: a systemic review.
Wang L, Qiu Q, Yang D, Cao C, Lu Y, Zeng Y
Front Pharmacol. 2024; 15:1173240.
PMID: 38584599
PMC: 10995224.
DOI: 10.3389/fphar.2024.1173240.
EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.
Achounna A, Ordaz-Rosado D, Garcia-Quiroz J, Morales-Guadarrama G, Milo-Rocha E, Larrea F
Int J Mol Sci. 2024; 25(6).
PMID: 38542136
PMC: 10970597.
DOI: 10.3390/ijms25063165.
Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications.
Dhayalan M, Wang W, Riyaz S, Dinesh R, Shanmugam J, Irudayaraj S
3 Biotech. 2024; 14(2):57.
PMID: 38298556
PMC: 10825110.
DOI: 10.1007/s13205-023-03901-8.
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V, Coleman N, Piha-Paul S, Tsimberidou A, Janku F, Rodon J
Cancer Res Commun. 2023; 4(2):378-387.
PMID: 38126764
PMC: 10860536.
DOI: 10.1158/2767-9764.CRC-22-0260.
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.
Whyte E, Nezu M, Chik C, Tateno T
Endocrinol Metab (Seoul). 2023; 38(6):631-654.
PMID: 37964483
PMC: 10764990.
DOI: 10.3803/EnM.2023.1838.
The Molecular Mechanism and Therapeutic Application of Autophagy for Urological Disease.
Chueh K, Lu J, Juan T, Chuang S, Juan Y
Int J Mol Sci. 2023; 24(19).
PMID: 37834333
PMC: 10573233.
DOI: 10.3390/ijms241914887.
Piperine Induces Apoptosis and Autophagy in HSC-3 Human Oral Cancer Cells by Regulating PI3K Signaling Pathway.
Han E, Choi E, Jeon S, Lee S, Moon J, Jung S
Int J Mol Sci. 2023; 24(18).
PMID: 37762259
PMC: 10530752.
DOI: 10.3390/ijms241813949.
Unraveling MYC's Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance.
Doha Z, Sears R
Pathophysiology. 2023; 30(3):400-419.
PMID: 37755397
PMC: 10537413.
DOI: 10.3390/pathophysiology30030031.
Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments.
Martins R, Jesus T, Cardoso L, Soares P, Vinagre J
J Pers Med. 2023; 13(7).
PMID: 37511745
PMC: 10381735.
DOI: 10.3390/jpm13071132.
Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.
Dutta S, Shah R, Singhal S, Dutta S, Bansal S, Sinha S
Drug Des Devel Ther. 2023; 17:1907-1932.
PMID: 37397787
PMC: 10312383.
DOI: 10.2147/DDDT.S409373.
Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma.
Sun K, Jin L, Karolova J, Vorwerk J, Hailfinger S, Opalka B
Cancers (Basel). 2023; 15(8).
PMID: 37190302
PMC: 10136620.
DOI: 10.3390/cancers15082373.
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson P, Malogolowkin M, Furman W, Piao J, Krailo M, Chung N
Pediatr Blood Cancer. 2023; 70(7):e30365.
PMID: 37073741
PMC: 10205685.
DOI: 10.1002/pbc.30365.
Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line.
Pagani F, Gryzik M, Somenza E, Cominelli M, Balzarini P, Schreiber A
J Pers Med. 2023; 13(3).
PMID: 36983607
PMC: 10056194.
DOI: 10.3390/jpm13030425.
Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation.
Zhang J, Wang X, Wang R, Chen G, Wang J, Feng J
Biomedicines. 2023; 11(3).
PMID: 36979928
PMC: 10045991.
DOI: 10.3390/biomedicines11030949.
